Respiratory Syncytial Virus News and Research

RSS
Discovery Labs reports preliminary results from Surfaxin Phase 2 trial in children with Acute Respiratory Failure

Discovery Labs reports preliminary results from Surfaxin Phase 2 trial in children with Acute Respiratory Failure

Motavizumab should not be licensed for marketing: FDA Antiviral Drugs Advisory Committee

Motavizumab should not be licensed for marketing: FDA Antiviral Drugs Advisory Committee

RNAi therapy shuts down gene critical to RSV, prevents virus replication

RNAi therapy shuts down gene critical to RSV, prevents virus replication

Effective infant vaccina­tion against pneumonia needed in sub-Saharan Africa

Effective infant vaccina­tion against pneumonia needed in sub-Saharan Africa

RSV appears to be predominant among Kenyan children hospitalized with severe pneumonia: Study

RSV appears to be predominant among Kenyan children hospitalized with severe pneumonia: Study

Health Canada grants Response Biomedical Class 3 Medical Device license for RAMP RSV Assay

Health Canada grants Response Biomedical Class 3 Medical Device license for RAMP RSV Assay

Alnylam Pharmaceuticals reports consolidated financial results for first quarter 2010

Alnylam Pharmaceuticals reports consolidated financial results for first quarter 2010

Discovery Labs reports first-quarter results, updates on Surfaxin and key pipeline programs

Discovery Labs reports first-quarter results, updates on Surfaxin and key pipeline programs

Pevion Biotech to present positive results of PEV4 RSV vaccine candidate at Vaccine Innovation Meeting

Pevion Biotech to present positive results of PEV4 RSV vaccine candidate at Vaccine Innovation Meeting

GenVec's 2009 revenues down 8%: MicroStockProfit.com

GenVec's 2009 revenues down 8%: MicroStockProfit.com

SJHS-HC tracks potential influenza cases using SafetySurveillor solution

SJHS-HC tracks potential influenza cases using SafetySurveillor solution

StockPreacher.com: GenVec's revenues for 2009 decline by 8%

StockPreacher.com: GenVec's revenues for 2009 decline by 8%

StockPreacher.com announces investment report featuring GenVec

StockPreacher.com announces investment report featuring GenVec

Discovery Laboratories reports net loss of $6.1M for fourth-quarter 2009

Discovery Laboratories reports net loss of $6.1M for fourth-quarter 2009

Alnylam Pharmaceuticals initiates ALN-RSV01 Phase IIb trial in adult lung transplant patients for RSV infection

Alnylam Pharmaceuticals initiates ALN-RSV01 Phase IIb trial in adult lung transplant patients for RSV infection

Cardiology 2010 conference focuses on current treatments for children with heart disease

Cardiology 2010 conference focuses on current treatments for children with heart disease

Novavax to discontinue collaboration agreement with ROVI Pharmaceuticals

Novavax to discontinue collaboration agreement with ROVI Pharmaceuticals

Researchers identify antiviral small molecule that is effective against numerous viruses

Researchers identify antiviral small molecule that is effective against numerous viruses

Clinical results of MedImmune's pivotal trial for motavizumab published

Clinical results of MedImmune's pivotal trial for motavizumab published

Researchers develop automated system to differentiate strains of influenza

Researchers develop automated system to differentiate strains of influenza